For COVID-19, small seems to be beautiful. First we had BioNTech, a tiny operation headed by a Turkish immigrant couple in Germany that gave us the Pfizer vaccine. Now along comes a small Maryland biotechnology company, Novavax, finally joining the ranks of high-profile COVID-19 vaccine developers, winning emergency authorisations for its candidate. (www.science.org/content/article/novavax a). The […]
COVAX
A new era for vaccines in Africa?
Pharma major BioNTech plans to start construction on its first start-to-finish vaccine plant in Africa in the middle of next year, Bloomberg reports (www.bloomberg.com/news/articles/2021-10-26/biontech-to-start-building-vaccine-plant-in-africa-next-year). The German company said it is developing the plans with the governments of Rwanda and Senegal, and initially, the factory will have an annual capacity of 50 million messenger RNA vaccine […]
Pandemic preparedness: better late than never
Billion-dollar plan Almost as if to make up for the lost Trump year during the pandemic, the White House has put together an ambitious new plan with a $65.3 billion price tag that could transform the way the United States responds to pandemics by vastly accelerating vaccine development, testing, and production. But is the plan […]
COVAX gets boon from multi-billion dollar commitment – but India’s absence leaves a hole
The COVAX facility designed to ensure equitable access to COVID-19 vaccines received a boost earlier this week to the tune of US$2.4 billion, following a summit where countries and private donors made the mammoth commitment. Nonetheless, the facility still reels from India’s step back understandable though it may be. COVAX is jointly led by the […]
COVAX facility reaches over 100 countries, as India reaffirms commitment
In the 42 days since the first shipment of vaccines through the COVAX facility arrived in Ghana, the World Health Organization (WHO) has announced in a statement that more than 100 countries have been reached. India, meanwhile, has reaffirmed its commitment to COVAX after it suspended exports amidst an ongoing surge in cases. The COVAX […]